The Priority Review

Tag

Tiotropium/Salmeterol

1 story

  1. Clinical trials

    Boehringer Ingelheim posts results of 1-yr Tiotropium/Salmeterol study in COPD

    Results for the 220-participant, Phase 3, randomized, triple-masked study were posted on October 29, 2026. The study compared FDC tiotropium/salmeterol with single agents and assessed FEV1, dyspnoea, health status and exacerbations.